Russia's sovereign wealth fund said last week that interim trial results showed Sputnik V is 92% effective at protecting people from the COVID-19 respiratory disease, and the country is preparing for mass inoculations. The Hungarian government did not respond to questions on whether it wanted to licence the Sputnik V vaccine at home or through the required EU process. EMA said that it had received no data from Russia or Hungary on Sputnik V or any other COVID-19 vaccine. IMPORT DOUBTSBut the EU questions even the import of Sputnik V by one of its member states. This rare exemption has been widely debated in recent months by EU experts, the European Commission said.

Source: Mint November 19, 2020 11:15 UTC